Drug intelligence / Profile preview

solasonine

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Solasonine is a steroidal glycoalkaloid found in various Solanum species, including Solanum nigrum and S. linnaeanum. It is a glycoside of solasodine and exhibits cytotoxic properties, particularly at high concentrations, by disrupting cell membrane integrity and inducing apoptosis. Traditionally used in herbal medicine for its anti-inflammatory and antiviral effects, recent research highlights its anticancer potential through mechanisms such as induction of apoptosis, cell cycle arrest (via AMPK/FOXO3A pathway), activation of ferroptosis, inhibition of PI3K/AKT and ERK/MAPK signaling pathways, suppression of neuropilin-1 (NRP1), and modulation of microRNA expression (e.g., miR-486-5p). Clinically, it has been included as a component in the topical formulation Curaderm BEC5 for actinic keratosis and certain skin cancers. However, high doses are toxic to humans due to their ability to disrupt cellular membranes[2][5][6][7][8].

Brand names
Curaderm BEC5
Other names
solasonineSolasoninTomatine solaradixine
02

Targets

AcetylcholinesteraseNRP1 (Neuropilin-1)MAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on solasonine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on solasonine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call